Acam2000 Injection, Powder, Lyophilized, For Solution
NDC 71665-430
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
Acam2000 (smallpox and mpox (vaccinia) vaccine, live) is a BLA-approved product labeled by Emergent Product Development Gaithersburg Inc.. This medication is typically used as a actively acquired immunity [pe]. It is supplied as a injection, powder, lyophilized, for solution for percutaneous administration. This product entry covers the primary NDC 71665-430 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
71665-430
Proprietary Name:
Acam2000
Non-Proprietary Name: [1]
Smallpox And Mpox (vaccinia) Vaccine, Live
Substance Name: [2]
Vaccinia Virus Strain New York City Board Of Health Live Antigen
NDC Directory Status:
Vaccine
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Injection, Powder, Lyophilized, For Solution
- A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route(s): [4]
Percutaneous - Administration through the skin.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
71665
Product Label ID:
FDA Application Number: [6]
BLA125158
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.
Marketing Timeline
Start Marketing Date: [9]
08-31-2007
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Code Structure Chart
Product Details
What is NDC 71665-430?
The NDC code 71665-430 is assigned by the FDA to the product Acam2000. It is commonly known by its generic name, smallpox and mpox (vaccinia) vaccine, live. This pharmaceutical product is labeled by Emergent Product Development Gaithersburg Inc. and is currently categorized as listed product. The medication is a injection, powder, lyophilized, for solution administered via percutaneous route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 71665-430-03. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
ACAM2000® is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What is the NDC to RxNorm Crosswalk for this product?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 833082 - smallpox (vaccinia) vaccine, live Injectable Solution
- RxCUI: 833082 - smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML Injectable Solution
- RxCUI: 833086 - ACAM2000 smallpox (vaccinia) vaccine, live Injectable Solution
- RxCUI: 833086 - smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML Injectable Solution [ACAM2000]
- RxCUI: 833086 - ACAM2000 500000000 UNT/ML Injectable Solution
Which are the Pharmacologic Classes of this product?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
* Please review the full disclaimer at the bottom of this page.
Patient Education
Smallpox/Mpox Vaccine
Why get vaccinated? Smallpox/Mpox vaccine can prevent infection with some types of orthopox viruses including Smallpox, Mpox, and Vaccinia viruses. Smallpox infection can cause a serious illness characterized by rash and fever that may result in death, for some. Mpox infection can cause an illness similar to Smallpox. Although generally milder, it can still cause death. Vaccinia virus infection can occur after someone is exposed to a person or an animal who has been exposed to the virus. It generally causes a self-limiting illness.
[Learn More]
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
